Editorial introductions

Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Elie Isenberg-GrzedaElie Isenberg-GrzedaDr Isenberg-Grzeda is an assistant professor of psychiatry at the University of Toronto, Canada and a staff psychiatrist specializing in psycho-oncology at Sunnybrook Health Sciences Centre in Toronto, Canada. He received his undergraduate degree in honours physiology from McGill University, Canada in 2005 and graduated from McGill medical school in 2009. In 2013, he completed his residency training in psychiatry at the Albert Einstein College of Medicine in New York, USA, where he served as chief resident. He went on to pursue a fellowship in consultation-liaison psychiatry and psycho-oncology at Memorial Sloan Kettering Cancer Center, New York, USA from 2013 to 2015, where he also served as chief fellow. He joined the University of Toronto Department of Psychiatry in 2015 as a clinician-teacher. He is involved in teaching at the undergraduate and postgraduate level, and has been the recipient of numerous teaching awards, including the Sunnybrook Department of Psychiatry Undergraduate Teaching Award as well as the University of Toronto MD Program Teaching Award of Excellence. He is a member of the Susan Leslie Multidisciplinary Clinic for Neuroendocrine Tumors. His clinical and research interests within psycho-oncology include non-alcoholic Wernicke encephalopathy (thiamine-related encephalopathy) in cancer patients, spiritual and existential distress among cancer patients, and medical assistance in dying. Janet EllisJanet EllisDr Janet Ellis completed her medical degree at Cambridge University, UK and her psychiatry residency in the UK and University of Toronto, Canada. She is now an Assistant Professor in the Department of Psychiatry at the University of Toronto and works as a Medical Psychiatrist in psychosocial oncology and acute physical trauma. She has also completed psychoanalytic training. She was Cancer Care Ontario Regional Clinical Lead for Psychosocial Oncology for five years and is now the Director of Psychosocial Care in Trauma at Sunnybrook Health Sciences Centre, Ontario, Canada. She has research interests in both psychosocial oncology (distress screening, integrated care, early identification of distress to improve outcomes) and trauma (prevention and management of PTSD, occupational stress injury, staff wellness). She is the psychiatry lead for the hospital's disaster planning committee and a cofounder of Disaster Psychiatry Canada. Nicole Marie Anna BlijlevensNicole Marie Anna BlijlevensDr Nicole Marie Anna Blijlevens is Internist-Hematologist and Head of the Department of Hematology at the Radboud University Medical Centre in Nijmegen, the Netherlands. She graduated with a PhD in medical sciences at the Radboud University Nijmegen, the Netherlands in 2005 with her thesis investigating mucosal barrier injury in hematopoietic stem cell transplant recipients. She continued her research in supportive care, especially focusing on complications of anti-cancer treatment such as infections, mucositis and graft-versus-host disease. She launched citrulline as a marker of intestinal therapy-induced mucositis and headed a landmark study of Palifermin in the prevention of oral mucositis in high-dose melphalan treated autologous stem cell transplant patients. She has headed up, as principal investigator, many (inter-)national clinical studies in hematology patients and was appointed Professor of Hematology in 2013. She has participated in various studies for the European Group for Blood and Marrow Transplantation (she chaired the EBMT Mucositis Advisory Group), the European Conference on Infections in Leukemia, the European Organisation for Research and Treatment of Cancer, and the HOVON (she chairs the HOVON Supportive Care Study Group). She founded the HEMA-ICU Study Group in the Netherlands, who study intensive supportive treatment in cancer patients together with intensivists nationwide. She is also an active member of the Multinational Association of Supportive Care in Cancer Mucositis Study Group and co-authored several updates of the MASCC/ISOO clinical practice guidelines for the management of mucositis. Recently she extended her scope into digital health and created CMyLife, a web-based platform for Chronic myeloid leukaemia (CML) patients, caregivers and relatives transforming Dutch hospital care for oral oncolytic drug consumers. She has authored more than 200 peer-reviewed research publications and 20 book chapters, all in the area of supportive cancer care. She has been the President of the National Society of Hematology and Treasurer of HOVON since 2015. Andrea M. StringerAndrea M. StringerDr Andrea M. Stringer leads research focussing on the role of the intestine related to vitamin D. Dr Stringer's broad area of research has focussed primarily on gut function, with the focus now linking the gut with other systems and the role of the gut microbiome in this environment. She is Deputy Director for Health and Biomedical Innovation research concentration at the University of South Australia, Australia and is Theme Leader for Gut Health. Dr Stringer's broad area of expertise is in developing strategies for preventing or treating oral and gastrointestinal damage following cancer treatments (mucositis) to reduce the burden of cancer. She has been involved in multiple pre-clinical investigations with growth factors, and probiotics to investigate their effectiveness in treating cancer treatment-induced mucositis. Dr Stringer's work has also encompassed identifying the mechanisms underpinning the damage that occurs following cancer treatments, with studies investigating the microbiome, inflammatory cytokines, the mucus barrier, and the enteric nervous system. Her current work focusses on the role of vitamin D in the intestine, specifically the effects of the microbiome, inflammatory cytokines and the mucus barrier.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.